康圣环球品牌怎么样 申请店铺

我要投票 康圣环球在精准医疗行业中的票数:63 更新时间:2025-01-22
康圣环球是哪个国家的品牌?「康圣环球」是康圣环球(北京)医学技术有限公司旗下著名品牌。该品牌发源于北京/海淀区,由创始人黄士昂在2007-11-20期间创立,经过多年的不懈努力和高速发展,现已成为行业的标杆品牌。
康圣环球怎么样

康圣环球医学特检集团(以下简称“康圣环球”)是中国首家和最大高端医学专科特检服务检验集团。康圣环球致力于引领中国专科特检技术和服务的进步,以促进中国专科诊疗和个性化医学的发展和提高。本着病人利益至上、医生需求第一的宗旨,康圣环球遵循国际规范、标准和行业指南,引进和研发世界上最先进的技术和专科特检方法,面向中国大型三级医院、专科医院和综合性医院提供全面、先进和准确的专科特检服务。集团创业和管理团队核心成员均在美国学术和产业界工作十年以上,视野广阔,经验丰富。集团得到了世界上最著名和最大的创投基金凯鹏华盈(KPCB)、晨兴创投、中经合、贝雅等几千万美元的资本支持。并在2011年6月27日,美国梅奥医学中心(MayoClinic)宣布与中国康圣环球医学特检集团正式签署一项长达数年的战略合作协议,梅奥向康圣环球注资,通过其医学检验与病理学部及其旗下的梅奥医学实验室,为康圣环球提供近3000项专业检测技术及实验室质量管理,国际认证标准、信息咨询、标准操作程序(SOPs)和方法学等相关技术,协助康圣环球加速发展其在中国的高品质特检服务,促进中国医学诊断和治疗水平的提高。

康圣环球在北京、上海、武汉已建和在建三万八千平方米具有国际先进水平的、具有国家资质的临床检验、科研合作和应用开发中心,拥有高分辨流式细胞仪、多色流式细胞分选与细胞培养、多色荧光适时幼态细胞扫描成像仪、第二代基因组学测序、基因芯片、全自动DNA/RNA提取、COBAS高灵敏度病毒载量系统、高精度质谱、质谱芯片、高压液相/气相层析、分子细胞、遗传与全自动核型扫描、变性高效色谱分析、分子病理、数字病理、液态芯片、单分子数字免疫、免疫组化、蛋白指纹图谱、激光共聚焦显微镜、电子显微镜等数十个技术平台和专业实验室,向全国三十一个省直辖市,六百多个城市的三千多家医院,尤其是千余家大型三级医院提供三千多项血液、肿瘤、遗传、心脑血管、感染性疾病、自身免疫性疾病等领域和内、外、妇、儿等专科的高精尖诊断检测,并通过与全球顶尖医疗科技机构和大型制药公司合作,向全国广大临床医师提供医学科研、药物试验和转化医学研究服务。


Kangsheng global medical special examination group (hereinafter referred to as "Kangsheng global") is the first and largest high-end medical special examination service inspection group in China. Kangsheng global is committed to leading the progress of special examination technology and services in China, so as to promote the development and improvement of specialized diagnosis and treatment and personalized medicine in China. In line with the tenet of putting patients' interests first and doctors' needs first, Kangsheng universal follows international norms, standards and industry guidelines, introduces and develops the most advanced technology and special examination methods in the world, and provides comprehensive, advanced and accurate special examination services for large-scale tertiary hospitals, specialized hospitals and general hospitals in China. The core members of the group's entrepreneurship and management team have worked in the academic and industrial circles of the United States for more than ten years, with broad vision and rich experience. The group has received capital support of tens of millions of US dollars from KPCB, Chenxing venture capital, China economic cooperation and paya, the world's most famous and largest venture capital fund. And on June 27, 2011, Mayoclinic of the United States announced that it has signed a strategic cooperation agreement with China global medical special inspection group for several years. Mayo has invested in global health. Through its Department of medical testing and pathology and its Mayo Medical Laboratory, it has provided global health with nearly 3000 professional testing technologies and laboratory quality management, international certification standards and information Consulting, SOPs, methodology and other related technologies will help Corson global to accelerate the development of its high-quality special examination services in China and promote the improvement of medical diagnosis and treatment level in China. Kangsheng global has established and is in the process of building 38000 square meters of clinical testing, scientific research cooperation and application development center with international advanced level and national qualification in Beijing, Shanghai and Wuhan. It has high-resolution flow cytometry, multi-color flow cell sorting and cell culture, multi-color fluorescence real-time young cell scanning imager, second-generation genomics sequencing, gene chip, and full-scale fluorescence Automatic DNA / RNA extraction, Cobas high-sensitivity viral load system, high-precision mass spectrometry, mass spectrometry chip, high-pressure liquid / gas chromatography, molecular cell, genetic and full-automatic nuclear scanning, denaturing high-performance chromatography, molecular pathology, digital pathology, liquid chip, single molecule digital immune, immunohistochemistry, protein fingerprint, laser confocal microscope, electron microscope, etc Ten technical platforms and professional laboratories provide more than 3000 hospitals in 31 provinces, municipalities directly under the central government and more than 600 cities in China, especially more than 1000 large tertiary hospitals, with more than 3000 high-end diagnostic tests in the fields of blood, tumor, genetics, cardio cerebrovascular, infectious diseases, autoimmune diseases, and in the fields of internal, external, women, children and other specialties, and have passed the world's top doctors Medical science and technology institutions and large pharmaceutical companies cooperate to provide medical research, drug testing and translational medical research services to clinicians across the country.

本文链接: https://brand.waitui.com/b8bc6d5cc.html 联系电话:18500087003

千城特选小程序码

7×24h 快讯

英国政府借款大幅增加,遵守财政规则面临挑战

英国政府2024年12月预算赤字激增,在利率居高不下、经济增长疲软的情况下,英国政府在遵守财政规则方面面临挑战。英国国家统计局周三表示,12月政府支出超过收入178亿英镑(219.9亿美元),赤字比去年同期高出101亿英镑,远高于预算责任办公室预测的142亿英镑。推动这一增长的一个因素是利息支付,比2023年同期高出38亿英镑。(新浪财经)

6分钟前

策源资本旗下基金入股灵童机器人

36氪获悉,天眼查App显示,近日,灵童机器人(上海)有限公司发生工商变更,新增成都策源广益数字经济股权投资基金合伙企业(有限合伙)、成都高新策源共创企业管理咨询合伙企业(有限合伙)为股东,同时注册资本由103万人民币增至约115.9万人民币。灵童机器人(上海)有限公司成立于2022年8月,法定代表人为陆杰,经营范围含智能机器人的研发、智能机器人销售、服务消费机器人销售、人工智能硬件销售、人工智能应用软件开发、数字内容制作服务等。

6分钟前

百万tokens降价至0.8元后,豆包模型毛利率已能达到50%

从多个知情人士处获悉,豆包大模型去年大幅降价后,毛利率依然为正。其中,字节跳动最新推出的豆包大模型1.5,在推理成本优化上取得进一步突破。在火山引擎上售卖API的Doubao-1.5-pro,毛利率仍能达到50%。去年5月,字节跳动正式对外发布豆包大模型。其中,豆包通用模型pro-32k版,模型推理输入价格仅每百万tokens0.8元,而当时市场上同规格模型的定价一般为每百万tokens120元,是豆包模型价格的150倍。(界面)

6分钟前

华林证券:2024年净利同比预增973.03%—1288.62%

36氪获悉,华林证券发布业绩预告,预计2024年归母净利3.4亿元—4.4亿元,同比增长973.03%—1288.62%。公司持续推进科技金融转型战略,财富管理线上业务收入同比大幅增加。自营投资业务积极把握市场机遇,进一步提升配置资产能力,收入大幅增加。此外,公司针对红博会展信托受益权资产支持专项计划仲裁事项,于2023年度计提预计负债约2.28亿元,导致2024年度相关营业外支出同比大幅下降。该笔营业外支出为非经常性损益。

6分钟前

北京君羊商贸有限公司获千万级Pre-A轮融资

36氪获悉,近日,北京君羊商贸有限公司宣布获得腾信投资领投的Pre-A轮千万级融资。公司创始人邵群表示,本轮融资资金主要投入到开拓业务、技术创新和拓宽市场这三大核心领域,同时将投入大量资金用于AI 算法的优化和模型训练。

6分钟前

本页详细列出关于康圣环球的品牌信息,含品牌所属公司介绍,康圣环球所处行业的品牌地位及优势。
咨询